West Pharmaceutical Services SG&A Expenses 2012-2026 | WST
West Pharmaceutical Services annual/quarterly sg&a expenses history and growth rate from 2012 to 2026. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- West Pharmaceutical Services sg&a expenses for the quarter ending March 31, 2026 were $0.100B, a 13.07% increase year-over-year.
- West Pharmaceutical Services sg&a expenses for the twelve months ending March 31, 2026 were $0.405B, a 19.22% increase year-over-year.
- West Pharmaceutical Services annual sg&a expenses for 2025 were $0.394B, a 16.28% increase from 2024.
- West Pharmaceutical Services annual sg&a expenses for 2024 were $0.339B, a 4.22% decline from 2023.
- West Pharmaceutical Services annual sg&a expenses for 2023 were $0.353B, a 11.52% increase from 2022.
|
West Pharmaceutical Services Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025 | $394 |
| 2024 | $339 |
| 2023 | $353 |
| 2022 | $317 |
| 2021 | $363 |
| 2020 | $302 |
| 2019 | $273 |
| 2018 | $263 |
| 2017 | $246 |
| 2016 | $240 |
| 2015 | $233 |
| 2014 | $229 |
| 2013 | $235 |
| 2012 | $218 |
| 2011 | $191 |
|
West Pharmaceutical Services Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $100 |
| 2025-12-31 | $107 |
| 2025-09-30 | $103 |
| 2025-06-30 | $96 |
| 2025-03-31 | $88 |
| 2024-12-31 | $85 |
| 2024-09-30 | $84 |
| 2024-06-30 | $83 |
| 2024-03-31 | $87 |
| 2023-12-31 | $90 |
| 2023-09-30 | $89 |
| 2023-06-30 | $88 |
| 2023-03-31 | $86 |
| 2022-12-31 | $86 |
| 2022-09-30 | $66 |
| 2022-06-30 | $82 |
| 2022-03-31 | $83 |
| 2021-12-31 | $98 |
| 2021-09-30 | $92 |
| 2021-06-30 | $93 |
| 2021-03-31 | $80 |
| 2020-12-31 | $76 |
| 2020-09-30 | $76 |
| 2020-06-30 | $78 |
| 2020-03-31 | $72 |
| 2019-12-31 | $69 |
| 2019-09-30 | $65 |
| 2019-06-30 | $70 |
| 2019-03-31 | $69 |
| 2018-12-31 | $60 |
| 2018-09-30 | $65 |
| 2018-06-30 | $70 |
| 2018-03-31 | $68 |
| 2017-12-31 | $60 |
| 2017-09-30 | $63 |
| 2017-06-30 | $61 |
| 2017-03-31 | $63 |
| 2016-12-31 | $61 |
| 2016-09-30 | $58 |
| 2016-06-30 | $63 |
| 2016-03-31 | $58 |
| 2015-12-31 | $62 |
| 2015-09-30 | $55 |
| 2015-06-30 | $61 |
| 2015-03-31 | $55 |
| 2014-12-31 | $59 |
| 2014-09-30 | $56 |
| 2014-06-30 | $58 |
| 2014-03-31 | $56 |
| 2013-12-31 | $60 |
| 2013-09-30 | $56 |
| 2013-06-30 | $60 |
| 2013-03-31 | $59 |
| 2012-12-31 | $59 |
| 2012-09-30 | $54 |
| 2012-06-30 | $54 |
| 2012-03-31 | $51 |
| 2011-12-31 | $48 |
| 2011-09-30 | $46 |
| 2011-06-30 | $46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $18.493B | $3.074B |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |